You just read:

Phase 2 Trial Demonstrates Long-acting Buprenorphine Blocks Opioid Effects and Suppresses Withdrawal Symptoms in Adults with Opioid Use Disorder

News provided by

Braeburn Pharmaceuticals

Jun 22, 2017, 12:00 ET